Sanara MedTech Inc. SMTI
35.06
(0.04)
(0.11%)
as of 25 Sep
- Market cap
- $322.5M
- P/E
- 0.0×
Follow SMTI
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(164.45%) | (167.53%) | (153.71%) | (147.79%) | |
| (46.97%) | (46.65%) | (40.54%) | (38.13%) | ||
ROIC |
19.20% | 12.92% | 14.38% | 13.49% | |
Return on Tangible Assets |
(262.45%) | (244.35%) | (186.99%) | (159.01%) | |
Average Days of Receivables |
43.30 | 42.47 | 46.24 | 41.79 | |
Free Cash Flow per Share |
(0.10) | 0.25 | 0.39 | 0.52 | |
Free Cash Flow |
(0.83) | 2.17 | 3.37 | 4.50 | |
Capital Expenditures |
(4.60) | (4.61) | (2.95) | (1.19) | |
Piotroski F-Score |
4.00 | 4.00 | 4.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
5.70% | 9.91% | 9.46% | 8.15% | |
Accounts Receivable Turnover |
8.78 | 8.44 | 8.42 | 8.94 | |
Accounts Payable Turnover |
6.03 | 3.89 | 4.98 | 5.29 | |
Inventory Turnover |
2.47 | 2.24 | 2.42 | 2.20 | |
Average Days of Payables |
53.95 | 113.50 | 44.19 | 66.83 | |
Days of Inventory on Hand |
156.53 | 191.63 | 149.69 | 165.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
3.09% | 4.92% | 4.54% | 4.53% | |
Selling, General and Administrative Expense of Revenue |
76.31% | 76.34% | 75.80% | 76.89% | |
Share Based Compensation of Revenue |
5.07% | 5.00% | 4.54% | 4.50% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.10) | (0.18) | (0.19) | (0.18) | |
Depreciation/Fixed assets |
12.35 | 9.25 | 8.07 | 7.51 | |
Capex/Depreciation |
(0.89) | (1.09) | (0.80) | (0.37) | |
Revenue per Share |
11.78 | 11.96 | 12.34 | 12.68 | |
Operating CF per Share |
0.44 | 0.79 | 0.73 | 0.66 | |
Capex per Share |
(0.53) | (0.53) | (0.34) | (0.14) | |
Capex to Sales |
0.05 | 0.04 | 0.03 | 0.01 | |
Net Profit Margin |
(36.80%) | (36.43%) | (31.24%) | (29.15%) |
Columns are period end dates